Loading...
Loading...
Browse all stories on DeepNewz
VisitWhat milestone will Neuralink's N1 implant achieve in human-machine interface by 2025?
Achieves full sensory feedback • 25%
Enables multi-device control • 25%
Significant AI integration • 25%
Other • 25%
Official Neuralink announcements, technology conferences, and media coverage
Neuralink's Coin-Sized N1 Implant with 1,024 Electrodes Enables Thought-Controlled Computing at 9.5 BPS
Dec 14, 2024, 11:25 PM
Neuralink's N1 implant is being hailed as a groundbreaking advancement in brain-computer interface technology. The device, which is the size of a coin, features 1,024 ultra-thin electrodes that can read neural signals, allowing individuals with paralysis to control computers, play games, and type through thought alone. With a bandwidth of 9.5 bits per second, the N1 device achieves approximately 50% of normal human capability. The technology is positioned as a significant step forward in merging human cognition with machines, with potential applications in technology, medicine, and human evolution. Neuralink's recent developments have garnered attention, particularly in light of its FDA milestones and the ongoing discussions surrounding its impact on enhancing human potential.
View original story
Restoration of hand movement • 25%
Restoration of leg movement • 25%
Improvement in speech • 25%
Other • 25%
Full success • 25%
Partial success • 25%
No success • 25%
Trial discontinued • 25%
Assistive technology for paralysis • 25%
Cognitive enhancement • 25%
Medical treatment for neurological disorders • 25%
Other • 25%
Recruitment completion • 25%
Initial results published • 25%
Trial expansion approved • 25%
Trial discontinued • 25%
Gaming • 25%
Virtual Reality • 25%
Augmented Reality • 25%
Other • 25%
Positive outcome • 25%
Negative outcome • 25%
Inconclusive outcome • 25%
Trial not completed • 25%
Successful with no issues • 25%
Successful with minor issues • 25%
Unsuccessful • 25%
Trial halted • 25%
Very Positive • 25%
Somewhat Positive • 25%
Neutral • 25%
Negative • 25%
New regulatory approval • 25%
New patient milestone • 25%
Commercial availability plans • 25%
New technological breakthrough • 25%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
Gaming • 25%
Other • 25%
Medical rehabilitation • 25%
Communication • 25%